Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

By C. Schuhmacher, S. Gretschel, F. Lordick, P. Reichardt, W. Hohenberger, C. Eisenberger, C. Haag, M. Mauer, B. Hasan, J. Welch and 10 more. Journal of Clinical Oncology, 2010

666 citations recorded by the source corpus.

Subfields: Gastroenterology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/9149dc08f190a67dbb0095fc2006938467954f9b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Cervantes
2. D. Arnold
3. M. Verheij
4. W. Allum
5. D. Cunningham

Citations in the corpus

• Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2010, background): “An EORTC study in which patients were randomised to surgery plus or minus biweekly cisplatin (50 mg/m(2)) and 5-FU in the de Gramont style also increased R0 resection rates in chemotherapy-treated patients but closed early due to poor accrual and is not powered to show a survival benefit [35].”